Crossmark

Prediction of the pharmacokinetics of the GLP-1 receptor agonist semaglutide in humans via a population pharmacokinetic model integrating interspecies scaling

Crossref DOI link: https://doi.org/10.1007/s40005-024-00717-3

Published Online: 2024-12-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Joonhee

Kim, Keon

Lee, Tae Suk

Cho, Hyunmin

Yoo, Seung-Dong

Kim, Tae Hwan

Shin, Beom Soo https://orcid.org/0000-0002-6706-5445
Shin, Soyoung https://orcid.org/0000-0001-8328-1087
Funding

Funding for this research was provided by:

National Research Foundation of Korea (NRF-2023R1A2C1007013, RS-2024-00348330)
License Information

Text and Data Mining valid from 2024-12-11

Version of Record valid from 2024-12-11
More Information

Article History

Received: 8 November 2024

Accepted: 26 November 2024

First Online: 11 December 2024

Declarations

:

: All authors (J. Kim, K. Kim, T.S. Lee, H. Cho, S.D. Yoo, T.H. Kim, B.S. Shin, and S. Shin) declare that they have no conflict of interest.

: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.

Document is current

Any future updates will be listed below